At the end of this activity, participants should be able to: • Appropriately administer a dose of neostigmine (2, 5).
Member, Prospective Member, Physician, Administrator, Committee Member, Vendor, Public, Related Organization, CRNA or Other Care Team Member, In-Training
The American Society of Anesthesiologists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Anesthesiologists designates this journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Society of Anesthesiologists remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of the American Society of Anesthesiologists to eliminate all situations of potential conflict of interest, but rather to enable those who are working with the American Society of Anesthesiologists to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. The American Society of Anesthesiologists educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all American Society of Anesthesiologists CME activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities. Editor-in-Chief: Evan D. Kharasch, M.D., Ph.D., has reported receiving consulting fees from TEN Healthcare. CME Editors: Leslie C. Jameson, M.D. has reported no relevant financial relationships with commercial interests. Dan J. Kopacz, M.D., has reported holding an equity position with SoloDex, LLC. Authors: Glenn S. Murphy, M.D., reported receiving funding from Merck and Co. Joseph W. Szokol, M.D., Michael J. Avram, Ph.D., Steven B. Greenberg, M.D., Torin D. Shear, M.D., Mark A. Deshur, M.D., Jessica Benson, B.S., Rebecca L. Newmark, B.A., and Colleen E. Maher, B.S., report no relevant financial relationships with commercial interests. Sorin J. Brull, M.D., F.C.A.R.C.S.I. (Hon), reports being a principal and shareholder for Senzime AB and receiving funds from ClearLineMD. Mohamed Naguib, M.D., M.Sc., F.C.A.R.C.S.I., reports no relevant financial relationships with commercial interests.